Search
for
Sort by
Research 30 of 1000+
- Queries and Minor Notes
- Vaccines, Infections, and Alopecia Areata
- Cutaneous manifestations of systemic infection in children
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Prenatal serological diagnosis of intrauterine cytomegalovirus infection.
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Therapeutic effects of growth factor cocktail (CellcurinTM) containing FGF5s (fibroblast growth factor 5 short) and NMN (nicotinamide mononucleotide) in patients with androgenetic alopecia: A split study
- The Skin and Subcutaneous Tissues
- Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results of a Prospective Multicenter Cohort
- Acute diffuse and total alopecia of the female scalp associated with borrelia-infection
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Cutaneous manifestations of COVID-19
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Cutaneous drug reactions
- Influenza-like symptoms and thrombocytopenia in a teenager
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- A rash diagnosis
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Pharmacological and Biological Efficacy of Chitosan-Based Materials
- Illuminating microflora: shedding light on the potential of blue light to modulate the cutaneous microbiome
- Alopecia-associated pseudocyst of the scalp
- Female Adolescent Hair Disorders